Domov › Akutna mieločna levkemija › Michigan › Ann Arbor
Klinične študije za Akutna mieločna levkemija v Ann Arbor, MI
17 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Ann Arbor in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Vključevanje udeležencevFaza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- in še 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- in še 4
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · 7 mi stran
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- in še 1
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi stran
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi stran
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Vključevanje udeležencevFaza 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Vključevanje udeležencevFaza 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Vključevanje udeležencevFaza 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Vključevanje udeležencevFaza 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Vključevanje udeležencevFaza 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Vključevanje udeležencevFaza 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Študije za Akutna mieločna levkemija v drugih mestih
- Houston, TX85 študij
- New York City, NY51 študij
- Boston, MA44 študij
- Seattle, WA41 študij
- Baldwin Park, CA40 študij
- Columbus, OH35 študij
- Philadelphia, PA34 študij
- Durham, NC33 študij
- Atlanta, GA31 študij
- Tampa, FL29 študij
- Chicago, IL26 študij
- Portland, OR25 študij
Druge študije v Ann Arbor
- Rak dojke27 študij
- Rak prostate27 študij
- Nemalicelični pljučni rak26 študij
- Rak (vse vrste)25 študij
- Rak pljuč23 študij
- Kolorektalni rak23 študij
- Srčno popuščanje22 študij
- Srčno-žilne bolezni16 študij
- Rak trebušne slinavke14 študij
- Melanom12 študij
- Možganska kap12 študij
- Ploščatocelični karcinom glave in vratu12 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.